Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041323
Filing Date
2023-08-10
Accepted
2023-08-10 16:11:26
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q svra-20230630.htm   iXBRL 10-Q 2018533
2 EX-31.1 svra-ex31_1.htm EX-31.1 18955
3 EX-31.2 svra-ex31_2.htm EX-31.2 18956
4 EX-32.1 svra-ex32_1.htm EX-32.1 14221
5 GRAPHIC img198090749_0.jpg GRAPHIC 3968
  Complete submission text file 0000950170-23-041323.txt   7802490

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT svra-20230630_def.xml EX-101.DEF 150924
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT svra-20230630_pre.xml EX-101.PRE 277332
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT svra-20230630.xsd EX-101.SCH 56083
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT svra-20230630_cal.xml EX-101.CAL 43904
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT svra-20230630_lab.xml EX-101.LAB 393361
64 EXTRACTED XBRL INSTANCE DOCUMENT svra-20230630_htm.xml XML 1543301
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 231159479
SIC: 2834 Pharmaceutical Preparations